These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4084656)

  • 21. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minor transplantation antigens: mouse models for human host-versus-graft, graft-versus-host and graft-versus-leukemia reactions.
    Simpson E
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):331-9. PubMed ID: 9883311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of genetic differences between mother and fetuses in the development of the graft vs host reaction induced in the mother].
    Fedosov EA; Fedorov GN; Kostiukov AA
    Biull Eksp Biol Med; 1980 Mar; 89(3):340-2. PubMed ID: 7388144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comment to Simonsen's spleen assay in the graft-versus-host reaction.
    Lemmel EM; Böhm F; Nouza K
    Folia Biol (Praha); 1966; 12(6):477-80. PubMed ID: 5954147
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction.
    Kimura T; Suzuki K; Inada S; Hayashi A; Isobe M; Matsuzaki Y; Tanaka N; Osuga T; Fujiwara M
    Hepatology; 1996 Oct; 24(4):888-94. PubMed ID: 8855193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease.
    Fontaine P; Roy-Proulx G; Knafo L; Baron C; Roy DC; Perreault C
    Nat Med; 2001 Jul; 7(7):789-94. PubMed ID: 11433342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of d,l-ethionine as a mechanism for pancreatic islet regeneration in dogs.
    Govendir M; Canfield PJ; Emslie DR; Watson AD; Church DB
    Aust Vet J; 2002; 80(1-2):75-82; discussion 82. PubMed ID: 12180885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of graft-versus-host disease in response to minor histocompatibility antigens on acute murine cytomegalovirus infection.
    Shanley JD; Korngold R; Forman SJ
    Transplantation; 1993 Aug; 56(2):487-9. PubMed ID: 8395102
    [No Abstract]   [Full Text] [Related]  

  • 33. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic and pancreatic dysfunction in anorexia nervosa: a report of two cases.
    Nordgren L; von Schéele C
    Biol Psychiatry; 1977 Oct; 12(5):681-6. PubMed ID: 588648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological studies of NK cell-deficient beige mice. I. Defective ability of beige lymphocytes to mediate local and systemic graft-versus-host reactions.
    Baca ME; Mowat AM
    Immunology; 1989 Jan; 66(1):125-30. PubMed ID: 15493274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal modification of tissue antigenicity and the histocompatibility-2 (H-2) locus.
    Uphoff DE
    J Natl Cancer Inst; 1970 Nov; 45(5):1035-7. PubMed ID: 18605431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.